180 related articles for article (PubMed ID: 37875835)
1. Stigma towards opioid use disorder in primary care remain a barrier to integrating software-based measurement based care.
Dela Cruz AM; Karns-Wright T; Kahalnik F; Walker R; Lanham HJ; Potter JS; Trivedi MH
BMC Psychiatry; 2023 Oct; 23(1):776. PubMed ID: 37875835
[TBL] [Abstract][Full Text] [Related]
2. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.
Dela Cruz AM; Walker R; Pipes R; Wakhlu S; Trivedi MH
Addict Sci Clin Pract; 2021 Feb; 16(1):12. PubMed ID: 33608060
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians.
Hooker SA; Crain AL; LaFrance AB; Kane S; Fokuo JK; Bart G; Rossom RC
Addict Sci Clin Pract; 2023 Feb; 18(1):10. PubMed ID: 36774521
[TBL] [Abstract][Full Text] [Related]
4. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
[TBL] [Abstract][Full Text] [Related]
5. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
[TBL] [Abstract][Full Text] [Related]
6. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
[TBL] [Abstract][Full Text] [Related]
7. Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?
Marsden J; Tai B; Ali R; Hu L; Rush AJ; Volkow N
Addiction; 2019 Aug; 114(8):1346-1353. PubMed ID: 30614096
[TBL] [Abstract][Full Text] [Related]
8. Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.
Franz B; Dhanani LY; Hall OT; Brook DL; Simon JE; Miller WC
Harm Reduct J; 2023 Dec; 20(1):180. PubMed ID: 38129903
[TBL] [Abstract][Full Text] [Related]
9. Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.
Foti K; Heyward J; Tajanlangit M; Meek K; Jones C; Kolodny A; Alexander GC
Drug Alcohol Depend; 2021 Aug; 225():108811. PubMed ID: 34175786
[TBL] [Abstract][Full Text] [Related]
10. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
[No Abstract] [Full Text] [Related]
11. Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors.
Windish DM; Catalanotti JS; Zaas A; Kisielewski M; Moriarty JP
J Gen Intern Med; 2022 Aug; 37(11):2650-2660. PubMed ID: 34729698
[TBL] [Abstract][Full Text] [Related]
12. Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization.
Kirane H; Drits E; Ahn S; Kapoor S; Morgenstern J; Conigliaro J; Enden J
J Opioid Manag; 2019; 15(3):193-204. PubMed ID: 31343721
[TBL] [Abstract][Full Text] [Related]
13. Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care.
Janet Ho J; Jones KF; Sager Z; Neale K; Childers JW; Loggers E; Merlin JS
J Pain Symptom Manage; 2022 Aug; 64(2):119-127. PubMed ID: 35561938
[TBL] [Abstract][Full Text] [Related]
14. Perceived stigma, barriers, and facilitators experienced by members of the opioid use disorder community when seeking healthcare.
McCurry MK; Avery-Desmarais S; Schuler M; Tyo M; Viveiros J; Kauranen B
J Nurs Scholarsh; 2023 May; 55(3):701-710. PubMed ID: 36317787
[TBL] [Abstract][Full Text] [Related]
15. Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.
Lanham HJ; Papac J; Olmos DI; Heydemann EL; Simonetti N; Schmidt S; Potter JS
JAMA Netw Open; 2022 May; 5(5):e2212419. PubMed ID: 35552721
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder.
Rossom RC; Sperl-Hillen JM; O'Connor PJ; Crain AL; Nightingale L; Pylkas A; Huntley KV; Bart G
Addict Sci Clin Pract; 2021 Jun; 16(1):37. PubMed ID: 34130758
[TBL] [Abstract][Full Text] [Related]
18. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
Speight C; Caiola C; Tyndall DE; Scott ES
J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
